Kudahetti, Sakunthala C <br/><br/>
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer.  [electronic resource] 

 -  Pathology  2010 
 - 519-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-3931 
<br/><br/><label>Standard No.: </label>10.3109/00313025.2010.508788  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--analysis<br/>Cyclin-Dependent Kinase Inhibitor p16--biosynthesis<br/>Cyclin-Dependent Kinase Inhibitor p21--biosynthesis<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Male<br/>Neoplasm Staging<br/>Prognosis<br/>Prostatic Neoplasms--metabolism<br/>Retinoblastoma Protein--biosynthesis<br/>Tissue Array Analysis<br/>Treatment Outcome